Two young infants in Louisiana have died from whooping cough within the past year, marking the state’s first pertussis fatalities since 2018. A separate child death involving both pertussis and influenza was confirmed in South Dakota. Together, these three pediatric deaths have occurred as national whooping cough case counts climb past 4,500, raising urgent questions about whether pandemic-era disruptions to childhood vaccination schedules are now producing deadly consequences.
Infant deaths in Louisiana and South Dakota signal a shifting threat
The Louisiana Department of Health reported that two young infants hospitalized with whooping cough died within the last year. Both deaths involved the most vulnerable age group for pertussis complications: babies too young to have completed their primary DTaP vaccine series. The agency described these as the first whooping cough deaths in Louisiana since 2018, ending a years-long stretch without fatalities just as cases began to surge across the state.
In South Dakota, health officials confirmed that a child died from a co-infection of pertussis and influenza. That dual infection illustrates a compounding risk: when respiratory pathogens overlap in a single patient, the combined toll can overwhelm a young immune system. The South Dakota Department of Health issued public guidance emphasizing transmission risks, early symptom recognition, and the value of vaccination after announcing the death.
These fatalities did not occur in isolation. The CDC tracks pertussis through the National Notifiable Diseases Surveillance System, and provisional data show case counts rebounding well above the suppressed levels seen during the early pandemic years of 2020 and 2021. The agency’s surveillance manual identifies infants as facing the highest risk of severe disease and death from pertussis, which is why federal immunization guidance specifically recommends Tdap vaccination during pregnancy to pass protective antibodies to newborns before they can receive their own shots.
Pandemic vaccination gaps and the pertussis rebound
A central question running through the current pertussis surge is whether measurable drops in childhood vaccination rates during the 2020 to 2022 school years created pockets of susceptibility that are now fueling larger outbreaks. Kindergarten DTaP coverage dipped in many states during that window as routine pediatric visits were delayed or skipped, and some families moved or changed insurance coverage without immediately reconnecting to a primary care provider. Public health officials are watching closely to see whether areas that experienced the steepest declines in routine immunizations are now reporting disproportionate pertussis activity.
The hypothesis that pertussis case rebounds are larger in states with sharper kindergarten DTaP declines, independent of broader population immunity, is plausible but difficult to prove with existing data. The CDC’s provisional surveillance counts are subject to revision and may undercount the true burden, while state-level breakdowns linking vaccination coverage directly to case rates have not been published in a single consolidated analysis. Local health departments often release outbreak summaries, but differences in testing, reporting, and contact tracing make comparisons challenging.
What is clear from the CDC’s pertussis surveillance framework is that the post-pandemic rebound is real and measurable. Pertussis follows cyclical patterns, with peaks every three to five years, but the current increase comes on top of a period when routine immunization schedules were disrupted nationwide. The Advisory Committee on Immunization Practices has long recommended a five-dose DTaP series for children and a Tdap booster during each pregnancy precisely because immunity to pertussis wanes over time, making consistent coverage essential to keeping case counts low.
For parents, the practical takeaway is direct. Infants who have not yet received at least their first two DTaP doses remain at serious risk. The CDC’s surveillance manual notes that pertussis-related deaths are tracked through a standardized Pertussis Death Worksheet, and the agency’s epidemiological data consistently show that the youngest patients account for the vast majority of fatal cases. Pregnant individuals who receive Tdap during the third trimester can transfer antibodies that protect newborns during the weeks before their own vaccinations begin, a strategy often described as “cocooning” the newborn with maternal immunity and vaccinated close contacts.
In Louisiana, officials have tried to lower access barriers by directing families to Medicaid and managed-care resources. The state’s health department points residents toward online tools that help them choose health coverage and locate participating clinics for recommended vaccines. Families comparing options can also use state resources to review plan benefits, including coverage for childhood immunizations and prenatal care, which are central to preventing severe pertussis in infants.
Gaps in the data and what to watch next
Several important questions remain unanswered. The Louisiana Department of Health has not disclosed the vaccination status of the two infants who died or the vaccination history of their mothers. Without that detail, it is impossible to determine whether these deaths resulted from missed prenatal Tdap doses, delayed infant vaccinations, underlying medical conditions, or some combination of factors. The state also has not published granular hospitalization numbers tied to its current pertussis case count, limiting the ability to assess how severe the broader outbreak has become beyond the two deaths.
At the national level, the specific figure of 4,500 cases is drawn from provisional surveillance data that the CDC cautions may be revised as states finalize their reporting. Weekly NNDSS tables are published and then reconciled over time, meaning the true cumulative count could shift in either direction as late reports are added and duplicate records are removed. No single CDC publication currently available provides a finalized 2025 or 2026 annual pertussis total, so the national picture remains a moving target rather than a fixed ledger.
The South Dakota case adds another layer of complexity. Because the child died from a co-infection of pertussis and influenza, attributing the death solely to whooping cough requires careful clinical and epidemiologic judgment. Influenza alone can cause severe respiratory distress in children, while pertussis is notorious for its prolonged coughing fits and risk of apnea in infants. When both pathogens are present, it can be difficult to disentangle which one played the dominant role in respiratory failure, or whether their combined effects were decisive. That ambiguity underscores how overlapping respiratory virus seasons can magnify risks for unvaccinated or partially vaccinated children.
Public health experts will be watching several indicators over the coming months. One is whether pertussis deaths remain confined to infants and very young children or begin to appear in older age groups, which could signal broader immunity gaps. Another is whether states report clusters tied to specific communities with lower vaccination coverage, such as certain school districts or geographic regions, which might allow for targeted outreach and catch-up clinics.
Officials are also monitoring how quickly routine vaccination rates recover from their pandemic-era dip. If pediatric practices and health systems can bring kindergarten DTaP coverage back to pre-2020 levels and sustain high uptake of Tdap during pregnancy, the current pertussis resurgence may settle into a familiar cyclical pattern without producing many more fatalities. If coverage remains patchy, however, the recent deaths in Louisiana and South Dakota may represent an early warning that the consequences of missed shots are arriving on a delay.
For now, the message from health authorities is consistent: pertussis is preventable, but prevention depends on timely vaccination. The three recent pediatric deaths highlight how quickly that protection can fail when schedules are interrupted, whether by a global pandemic, gaps in insurance, or simple logistical hurdles. As national case counts climb, the question is not only how high this pertussis wave will crest, but whether the systems meant to shield the youngest children can be reinforced before more families face the same loss.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
